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George W. Rodway, RN, PhD 
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The physiologic response to hypoxia may be determined by variables such as exposure pattern 
and inducible nitric oxide synthase (iNOS) expression. Blood pressure (BP) and heart rate (HR) 
responses to daily exposure (X 3 days) of intermittent hypoxia (IH) vs. continuous hypoxia (CH) 
(equivalent total exposure time) were compared. The relation between BP and HR responses and 
iNOS expression under IH and CH conditions was also examined. On 3 consecutive days, 10 
normal males had six 10-min. hypoxic exposures (oxyhemoglobin saturation, SpO2: 80-90%), 
with each exposure separated by 10 min. of normoxia. Subjects also had 3 consecutive days of 
CH (60 min/day; SpO2: 80-90%). IH and CH exposure blocks were separated by a >7 days. BP, 
HR, and SpO2 were recorded during the 5 min. prior to and the last 5 min. of each daily IH and 
CH exposure. Venous blood for iNOS mRNA was obtained before exposure on day 1, and 2 hrs. 
after the last exposure  on day 3. HR, systolic and diastolic BP were significantly (p<0.05) 
increased from baseline- to end-exposure on each day, regardless of IH or CH. There was a 
significant negative correlation (p<0.01) between both diastolic and mean BP with iNOS at the 
end of the day 3 IH session. Hypoxic stress reflected by IH and CH is associated with significant, 
but comparable changes in BP. Negative correlation between BP and iNOS mRNA in 
conjunction with IH, but not CH, exposure suggests that the hemodynamic response to IH may 
be modulated by iNOS. 
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1. INTRODUCTION 
It is estimated that 12-20 million people in the United States have obstructive sleep apnea 
(OSA), a disorder typified by nightly exposure to intermittent hypoxia (IH) secondary to upper 
airway obstruction during sleep (Sieck, 2001). Epidemiologic, retrospective, and cross-sectional 
studies have identified associations between OSA and increased risk for cardiovascular disease, 
e.g., stroke, ischemic heart disease, and systemic hypertension (Leung & Bradley, 2001; 
Neubauer, 2001; Prabhakar, 2002). There is particularly strong evidence of an association 
between OSA and systemic hypertension, independent of age, obesity or other confounding 
factors (Leung & Bradley, 2001; Nieto et al., 2000; Peppard, Young, Palta, & Skatrud, 2000; 
Young et al., 1997). Consequently, there is an emerging consensus that OSA has serious 
physiologic consequences beyond those associated with sleep disruption (Brooks, Horner, Kozar, 
Render-Teixeir, & Phillipson, 1997; Fletcher, Lesske, Qian, Miller, & Unger, 1992; Neubauer, 
2001). 
During apneic episodes, mechanical and neurochemical responses produce dramatic 
fluctuations in blood pressure (BP) and heart rate (HR) in conjunction with changes in 
respiration (Lam & Ip, 2002). Current thinking implicates the pathophysiologic consequences of 
these episodic surges as the mechanism responsible for cardiovascular disease, including 
systemic arterial hypertension and myocardial infarcts in patients with OSA (Leung & Bradley, 
2001). Fragmented sleep is also characteristic of OSA, but experimental studies in dogs (Brooks 
et al., 1997) and rats (Fletcher et al., 1992) support the hypothesis that IH, not sleep 
fragmentation, causes persistent hypertension (Neubauer, 2001). 
There is also emerging evidence that the pattern of hypoxia (repetitive or continuous) is a  
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critical factor in determining physiologic response, with IH being a more potent stimulus than 
continuous hypoxia (CH). For instance, the reduction in ventilation following initial 
augmentation during CH has been shown to be attenuated during IH in adult humans 
(Nieuwenhuijs, Sarton, Teppema, & Dahan, 2000) and animals (Gozal & Gozal, 1999). This 
ventilatory enhancement persists during normoxia following IH exposure (Cao, Zwillich, 
Berthon-Jones, & Sullivan, 1992). Similarly, animal studies have shown that IH produces 
marked increases in BP and sympathetic activity which were not seen following exposure to a 
comparable duration of CH (Prabhakar, 2002; Young et al., 1997).  
The major difference between IH and CH relates to episodic reoxygenation in the former, 
but not in the latter (Prabhakar, 2001, 2002).  In this context, IH seems to resemble ischemia-
reperfusion (Prabhakar, 2002). Prior work indicates that the episodic re-oxygenation that occurs 
during IH represents an oxidative stress that results in cellular generation of reactive oxygen 
species (Prabhakar, 2001, 2002). There are a number of ways that oxidative stress could mediate 
effects of IH (Prabhakar, 2001). Regardless of the mechanism, there is increasing recognition 
that oxidative stress is likely influential in the transcriptional activation of the specific genes 
through which hypoxia influences adaptive (or maladaptive) responses (Prabhakar, 2001). 
Hypoxia-inducible factor-1 alpha (HIF-1α), a transcription factor, has been the focus of much 
recent interest as the possible factor responsible for signaling specific gene expression and the 
resultant physiologic response to IH. HIF-1α regulates expression of a number of genes 
associated with hypoxic adaptation, including those involved in vasomotor control.   
However, there are major gaps in knowledge regarding the linkage of biologic and 
molecular responses to IH with physiological responses. The proposed study in humans 
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 represents an initial step in increasing understanding of the physiological importance of episodic 
periods of IH and CH on BP and HR, as well as the potential modulator roles of oxidative stress 
and HIF-1α transcription activation.  Normal subjects will be recruited, rather than patients with 
OSA, to eliminate potentially confounding effects of the underlying disease process. 
1.1. Purpose 
The purpose of this study was to define and compare the impact of short-term exposure to 
IH and CH with regard to selected cardiovascular variables as well as circulating and exhaled 
biomarkers of oxidative stress and HIF-1α (at the level of messenger ribonucleic acid [mRNA]). 
Results were assessed to determine if a potential relationship exists between changes in these 
biologic markers and changes in the cardiovascular variables. 
1.2. Specific Aims 
1) To assess and compare the cardiovascular effects of short-term IH versus short-term CH 
exposure to a fraction of inspired oxygen (FIO2) that results in an arterial oxygen saturation 
(SpO2) between 80 and 90%; 
2)  To assess and compare the effect of IH and CH on circulating and exhaled biomarkers of  
oxidative stress and HIF-1α;  
3) To explore the relationship between the cardiovascular impact of IH / CH and oxidative 
stress and HIF-1α. . 
1.3. Research Questions and Hypotheses 
RQ 1 - Is there a difference in the impact of short-term exposure to IH versus CH on selected 
cardiovascular variables (systolic and diastolic blood pressure [SBP, DBP]) and heart rate 
(HR)?  
3 
 H1.1 - SBP, DBP and HR will increase to a greater extent following short-term 
exposure to IH compared to short-term exposure to CH. 
H1.2 - The increase in SBP, DBP and HR will be greater following 3 consecutive 
days of  IH exposure compared to 3 consecutive days of CH exposure. 
RQ 2 - What is the effect of IH and CH on circulating and exhaled biomarkers of oxidative stress 
and HIF-1α activation (mRNA)? 
H2.1 - Circulating and exhaled biomarkers of oxidative stress and HIF-1α 
activation (mRNA) will increase to a greater extent following IH compared to 
CH. 
H2.2 - The increase in circulating and exhaled biomarkers of oxidative stress and 
HIF-1α activation (mRNA) will be greater following 3 consecutive days of IH 
exposure compared to 3 consecutive days of CH exposure. 
RQ3 - Is there a relationship between the increase in circulating and exhaled biomarkers of 
oxidative stress and HIF-1α activation (mRNA) and the change in SBP, DBP or HR?  
H3.1 - Participants with the greatest increase in circulating and exhaled markers 
of oxidative stress and HIF-1α (mRNA) will demonstrate the greatest change in 
SBP, DBP and HR during IH exposure on a given day and across 3 consecutive 
days of exposure 
H3.2 - Participants with the greatest increase in circulating and exhaled markers 
of oxidative stress and HIF-1α (mRNA) will demonstrate the greatest change in 
SBP, DBP and HR during CH exposure on a given day and across 3 consecutive 
days of exposure. 
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1.4. Definition of Terms 
IH: Exposure to a fraction of inspired oxygen (FIO2) that results in a peripheral arterial oxygen 
saturation (SpO2) between 80 and 90% for six 10 minutes periods (interrupted by 10 minute 
intervals of normoxia). 
CH: Exposure to a FIO2 that results in a SpO2 between 80 and 90% for 60 consecutive minutes. 
Cardiovascular variables: Systolic blood pressure, diastolic blood pressure and heart rate. 
Circulating and exhaled biomarkers of oxidative stress: Any oxygen species capable of 
independent existence that contains one or more unpaired electrons, e.g., nitric oxide (NO), 
superoxide, or hydroperoxyl, is known as a free radical, also called reactive oxygen (or nitrogen) 
species, capable of inducing oxidative stress. Exhaled NO will be the primary exhaled biomarker 
of interest in this study, and is measured using exhaled breath. There are many known circulating 
biomarkers of oxidative stress. Inducible nitric oxide synthase (iNOS), one of the target genes of 
HIF-1α and a precursor of NO, will be the primary circulating biomarker of interest in this study 
and will be measured using venous blood. 
HIF-1α activation (mRNA): HIF-1 is a transcriptional activator that mediates changes in gene 
expression (e.g. iNOS) in response to changes in cellular oxygen concentrations. HIF-1 is a 
heterodimer consisting of, in part, an oxygen-regulated HIF-1α subunit. The regulation of HIF-
1α expression and activity in vivo occurs at multiple levels, including messenger ribonucleic 
acid (mRNA) expression, which carries the genetic code to the cytoplasm for controlling the 
formations of the proteins that are responsible for phenotypic adaptations (or maladaptations). 
5 
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1.5. Conceptual Framework 
The conceptual framework shown in Figure 1 depicts the proposed relationships between  
 
IH and CH and the variables to be examined in this study.  As conceptualized, IH and CH 
influence SNA and HIF-1α activity, with IH having a more marked effect (darker lines) and CH a 
more minor effect (lighter lines).   
With the onset of IH or CH, 1) HIF-1α transcriptional activity increases, mediated by NO, 
emanating from cell mitochondria; 2.) this in turn increases expression of hypoxia-inducible 
genes (target genes); 3.) which in turn leads to increased generation of NO in cell mitochondria, 
and 4.) inhibition of HIF-1α transcriptional activity and subsequent inhibited expression of target 
genes influenced by HIF-1α (e.g the hypoxia-inducible genes downstream from HIF-1α) due to 
interference with HIF-1 DNA binding.  The extent of inhibition in HIF-1α is dependent on NO 
levels, i.e., the higher the level of generation of NO, the greater the inhibition of HIF-1α activity.  
This action and reaction can be viewed as analogous to a negative feedback loop. The NO is 
generated by the hypoxia-inducible transcription of the gene encoding iNOS. 
IH and CH also increase SNA and hence sympathetic vasoconstrictor tone via peripheral 
chemoreceptor stimulation manifested as changes in HR and BP.  HIF-1α regulates expression 
of genes, e.g., iNOS, involved in regulation of neurotransmitter properties also affecting SNA 
and vasomotor control.  
 
 
 
IH
CH
H IF-1α SNA
CV
(HR,BP)
Target 
genes   e.g., 
iNOS
CV
(HR,BP)
NO
NO
Marked IH Effect
C-V =    Cardiovascular 
Activity
SNA =    Sympathetic Nerve 
Activity
NO
NO
Minor CH Effect
NOS, etc.
 
Figure 1  Conceptual framework: The conceptual relationship of study variables. 
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2. BACKGROUND AND SIGNIFICANCE 
2.1. Cardiovascular Effects of Normal Sleep 
During normal sleep, there is a progressive reduction in central ventilatory drive 
accompanied by a reduction in ventilation and SpO2.  In deeper stages of sleep, respiration is 
predominately under metabolic control with a very regular pattern.  Cardiovascular autonomic 
regulation mirrors the change in respiratory control.  Parasympathetic nervous system tone 
increases and sympathetic nervous system activity (SNA), BP and HR decrease, and the 
cardiovascular system reaches a state of hemodynamic and autonomic quiescence during which 
myocardial workload is decreased (Leung & Bradley, 2001). 
2.2. Cardiovascular Effects of OSA 
Patients with OSA experience repetitive episodes of apnea, from several to as many as 
100 times per sleep hour, as a result of upper airway collapse and obstruction at the level of the 
pharynx.(Lam & Ip, 2002).  The shift from apnea to normal breathing causes abrupt surges as 
cardiovascular autonomic nervous system activity and hemodynamic variables (BP, HR) 
oscillate between apneic and ventilatory phases. Surges in HR and BP typically occur 5-7 
seconds after apnea termination,(Ringler et al., 1990; Tilkian et al., 1976) coincident with arousal 
from sleep, peak ventilation, and the nadir of SpO2. The usual fall in HR and BP that 
accompanies normal sleep is counteracted by these repetitive surges (Leung & Bradley, 2001). 
Hypoxia stimulates peripheral chemoreceptors which, in turn, increases sympathetic outflow and 
BP (Lam & Ip, 2002). During obstructive apneas, the sympathoexcitatory effect of hypoxia is 
amplified by carbon dioxide retention associated with cessation of breathing (Leung & Bradley, 
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 2001).  This results in increased sympathetic vasoconstrictor tone (Somers, Mark, Zavala, & 
Abboud, 1989). Hence, it follows that OSA is associated with chronic abnormalities of 
cardiovascular autonomic nervous system regulation during sleep including increased SNA, 
reduced baroreflex sensitivity and HR variability, and increased BP variability (Carlson et al., 
1993; Hedner, Ejnell, Sellgren, Hedner, & Wallin, 1988; K Narkiewicz et al., 1998; K. 
Narkiewicz, van de Borne, Cooley, Dyken, & Somers, 1998; Somers, Dyken, Clary, & Abboud, 
1995). Further, several studies have shown that individuals with OSA have higher SNA during 
sleep and wakefulness than control subjects (Carlson et al., 1993; Hedner et al., 1988; Somers et 
al., 1995). 
2.3.    Physiologic Effects of IH   
The ventilatory response to IH is believed to be related to long-term facilitation of 
ventilatory activity by a mechanism that may be serotonergic-dependent (Turner & Mitchell, 
1997). Neubauer (Neubauer, 2001) has suggested the sympatho-excitatory region of the rostral 
ventrolateral medulla as a potential site of ventilatory adaptation to IH, since neurons in this 
region are sensitive to the direct effects of hypoxia (Mazza, Edelman, & Neubauer, 2000). In 
contrast to CH, in which there may be a biphasic ventilatory response characterized by a 
reduction in ventilation following initial augmentation, IH appears to be associated with 
attenuation of this decline in adult humans (Nieuwenhuijs et al., 2000) and animals (Gozal & 
Gozal, 1999). 
Emerging evidence suggests that IH has the potential to alter ventilatory neuronal 
activity. (Gozal & Gozal, 1999) tested the hypothesis that repeated short exposures to hypoxia 
modifies hypoxic ventilatory response in an animal model. The study involved 30-minute 
hypoxic challenges in 2 to 3-day old rat pups before and 6 hours after completing a series of 8 IH 
9 
 cycles consisting of 5 minutes hypoxia and 10 minutes normoxia, or normoxia throughout.  
Periods of IH were associated with ventilatory enhancement that persisted during normoxia 
following the IH.  Cao et al.(Cao et al., 1992) examined the normoxic ventilatory response 
following successive episodes of 2-minute eucapnic hypoxic challenges in awake tracheotomized 
dogs and reported similar findings.  In contrast, a similar facilitation of ventilatory response was 
not demonstrated when awake goats were exposed to either 4 hours (n=10) or 30 minutes (n=7) 
of CH (Dwinell, Janssen, & Bisgard, 1997). In the latter study, minute ventilation, tidal volume, 
and frequency were measured before, during, and after the CH exposure.   
Additional studies suggest that IH may augment SNA in animals and healthy humans.  
Bao et al.(Bao, Metreveli, Li, Taylor, & Fletcher, 1997) studied the role of renal artery 
sympathetic nerves and the adrenal medulla in BP increase during IH in rats. Adult male rats had 
either an adrenal medullectomy (n=22), bilateral renal artery denervation (n=19), or sham 
surgery (n=36). Rats from each group were subjected to IH (FiO2 lowered twice per minute for 
6-8 hours) for 35 consecutive days. Results confirmed that the IH-mediated increase in diurnal 
BP requires both intact renal artery nerves, as well as an intact adrenal medulla. Xie et al.(Xie et 
al., 2000) reported that even short-term IH exposure (20 seconds per minute of isocapnic hypoxia 
to SpO2 = 82 ± 1% for 20 minutes) augmented SNA in 7 healthy humans. SNA remained 
elevated for at least 20 minutes after return to normoxic baseline SpO2. Arabi et al.(Arabi et al., 
1999) reported that even 2 continuous 8-hour nocturnal exposures (successive nights) to 
hypobaric hypoxia (SpO2 = 73±4%) in 10 healthy normotensive subjects was associated with 
elevated DBP that persisted after termination of hypoxic exposure.  
There is also evidence from studies utilizing adult rats exposed to periods of IH for 8 
hours per day for 30 (Greenberg, Sica, Batson, & Scharf, 1999) and 70 (Kraiczi et al., 1999) days 
10 
 suggesting that IH exerts a greater influence on sympathetic activity and BP than CH. Recent 
research with a rat model provides preliminary evidence that the link between IH and 
hypertension may be mediated by decreased activity of NO, an exhaled biomarker of oxidative 
stress (Fletcher, 2001).  In addition, two recent studies in humans support the theory of increased 
resting basal vascular tone through lack of NO activity in the OSA patient. Carlson et al. 
(Carlson, Rangemark, & Hedner, 1996) showed that forearm vascular relaxation to acetylcholine 
(which is NO dependent) decreased in apneic subjects compared with nonapneic controls. 
Duchna et al. (Duchna et al., 2000) found that endothelium-dependent NO (bradykinin) vascular 
relaxation was depressed in OSA patients compared with controls, whereas NO independent 
(nitroglycerine) vasorelaxation was unaffected. In summary, the suggestion that specifically 
implicates the repetitive nature of hypoxic exposure as being pivotal in the development of 
cardiovascular (e.g. BP) alterations (Prabhakar, 2001) is gaining ever-increasing support from 
the investigational community.  
2.4. Response to IH may be related to Oxidative Stress and HIF-1α Gene Expression 
Since episodic hypoxia/re-oxygenation and sympathetic activation are associated with  
oxidative stress (Leung & Bradley, 2001), a relationship between oxidative stress and changes in 
BP during IH is plausible. Inter-individual variability in cardiovascular responses to IH may be 
due to differences in genetic expression (Kraiczi et al., 1999). Kraiczi et al (Kraiczi et al., 1999) 
reported that increased left ventricular (LV) weight-to-body weight ratio and enhanced LV 
expression of atrial natriuretic peptide mRNA was present in 6 spontaneously hypertensive rats, 
but not in the 6 normotensive rats after 70 days of IH (8 hours per day). This preliminary 
evidence indicates that at least some long-term consequences of IH may be modified by 
11 
 preexisting constitutional (genetic) traits. Further testing, as proposed in this study, is necessary 
to confirm this potential. 
 HIF-1α regulates expression of a number of genes associated with hypoxic adaptation, 
including those involved in vasomotor control such as endothelin-1, adrenomedullin, iNOS; iron 
metabolism, and HO-1 products, e.g., CO, bilirubin, biliverdin, and ferritin (G. Semenza, 2000). 
HO-1 and associated substances have vasodilator, anti-inflammatory and neurotransmitter 
properties that are important in the response to oxidative stress (Ameredes et al., 2002; 
Prabhakar, 2001; Sethi & Choi, 2001). HIF-1α also plays a role in the development of 
pulmonary artery hypertension and pulmonary artery medial hypertrophy with hypoxic exposure 
(G. L. Semenza, 2001). Mice experienced delayed development of pulmonary artery 
hypertension and right ventricular (RV) hypertrophy during CH exposure when the gene 
encoding for HIF-1α was inactivated (G. Semenza, 2000; G. L. Semenza, 2001; Yu et al., 1999). 
Analysis of knockout mice has also demonstrated that HIF-1α is required for embryonic 
development and survival. Conversely, mice that are heterozygous for the knockout allele and 
thus partially HIF-1α deficient develop normally (G. L. Semenza, 2001). Yu et al. (Yu et al., 
1999) compared the physiological response of partially HIF-1α deficient heterozygous mice to 
the response of their normal (wild-type) littermates after breathing 10% oxygen for 1 to 6 weeks. 
The partially HIF-1α deficient heterozygous mice demonstrated significantly delayed 
development of polycythemia, RV hypertrophy, pulmonary hypertension, and pulmonary 
vascular remodeling compared with their normal littermates. These findings provide suggestive 
evidence that partial inhibition of HIF-1α activity may in the future provide a means to prevent 
pulmonary vascular remodeling in at-risk patients with diseases due to or exacerbated by IH or 
CH. 
12 
 2.5. Significance and Innovation 
No prior studies have explored the potential role of HIF-1α or oxidative stress in 
producing individual variability in response to IH and CH.  Notable cardiovascular sequelae such 
as stroke, ischemic heart disease, and systemic hypertension do not develop in all persons who 
experience IH. Conceptually, oxidative stress arising from IH may play a pathophysiologic role 
in these consequences (Neubauer, 2001). Clinical research utilizing awake, normal subjects may 
provide beginning support for the physiological importance of episodic periods of IH on 
clinically important physiological parameters, the mediating effects of biomarkers of oxidative 
stress and HIF-1α transcription activation.  
It is intriguing to speculate that inter-individual variability of HIF-1α activation and 
oxidative stress explains at least some of the variability in response to IH between individuals. 
Since episodic hypoxia/re-oxygenation and sympathetic activation are associated with oxidative 
stress (Leung & Bradley, 2001), a relationship between oxidative stress and changes in 
cardiovascular response to IH is logical. Current thinking suggests that HIF-1α regulates 
expression of a number of genes associated with hypoxic adaptation, including those involved in 
vasomotor control such as endothelin-1, NO synthase, and HO-1 products such as CO (G. 
Semenza, 2000). HO-1 and associated substances have vasodilator, anti-inflammatory and 
neurotransmitter properties that are important in the response to oxidative stress (Ameredes et 
al., 2002; Prabhakar, 2001; Sethi & Choi, 2001). HIF-1α also plays a role in the development of 
pulmonary artery hypertension and pulmonary artery medial hypertrophy with hypoxic exposure 
(G. L. Semenza, 2001). 
Inter-individual variability in cardiovascular responses to IH may be due to differences in 
genetic expression. Kraiczi et al (Kraiczi et al., 1999) reported that increased left ventricular 
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 (LV) weight-to-body weight ratio and enhanced LV expression of atrial natriuretic peptide 
mRNA was present in 6 spontaneously hypertensive rats, but not in the 6 normotensive rats after 
70 days of IH (8 hours per day). This preliminary evidence indicates that at least some long-term 
consequences of IH may be modified by preexisting constitutional (genetic) traits. Further 
testing, as proposed in this study, is necessary to confirm this potential. 
If in fact inter-individual variability in cardiovascular responses to IH is due at least in 
part to differences in genetic expression, assessment of oxidative stress and HIF-1α expression 
may facilitate risk stratification to identify those individuals most susceptible to adverse 
cardiovascular outcomes. Better understanding of the consequences of IH and those factors that 
influence expression of these consequences may translate into improved development of 
effective therapeutic paradigms. Successful risk stratification and aggressive long-term 
management of patients most susceptible to adverse cardiovascular outcomes may eventually 
allow acute-care health resources to be optimally directed to patients other than those suffering 
the sequelae of long-term IH. 
Translational research of this sort, meant to bridge the gap between the bench and the 
bedside, will not have immediate bedside nursing implications. The ability to identify and thus 
aggressively manage, in a practical clinical fashion, those individuals most susceptible to the 
adverse cardiovascular outcomes of IH will be a goal for the near future. Convenient and cost-
effective testing for presence of transcription factor and target gene activation will be needed 
before clinicians are able to provide useful and effective traditional therapy in a timely, 
aggressive manner.  
 Manipulation of genetic factors, already successful in animal models, may also become 
an important aspect of therapeutic paradigms for those individuals most susceptible to the 
14 
 adverse cardiovascular outcomes of IH. An example of the future possibilities of gene 
manipulation is illustrated by mice that experience delayed development of pulmonary artery 
hypertension and right ventricular hypertrophy during exposure to hypoxia when the gene 
encoding for HIF-1α is inactivated (G. Semenza, 2000; G. L. Semenza, 2001; Yu et al., 1999). 
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3. METHODOLOGY 
3.1. Research Design 
The study used a within-subjects repeated measures design. Each subject participated in 3 
blocks (acclimatization, 3 consecutive days of IH, 3 consecutive days of  CH) as shown below. 
The order of the IH and CH blocks was determined by subject availability. 
 
 
 
   
   
Normoxia 
 
Hypoxia 
60 minutes 
 
Acclimatization 
IH Block 10 10 10 10 10 10 10 10 10 10 10 10 
  CH Block 
10 60 minutes 
 
Figure 2 Scheme of normoxic (acclimatization) and hypoxic (IH and CH) exposures  
 
3.2. Research Methods 
3.2.1. IH Block  
 On each of 3 consecutive days, participants experienced 6 exposures to hypoxia as 
follows: 1) Subjects initially breathed air (fraction of inspired oxygen, FIO2=21%, the percentage 
that is in room air) through a commercially available facemask for 10 minutes;  2) A FIO2 
~13.5% was administered via the facemask with subsequent adjustment of the FIO2 to achieve 
and maintain an arterial oxyhemoglobin saturation by pulse oximetry (SpO2) = 80-90% for 10 
minutes; 3) IH ended and room air was administered for 10 minutes. Steps #1-3 were repeated 
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 for a total of 6 IH exposures. Each day required approximately 3-4 hours of the participant’s 
time, including calibration, application and removal of the monitoring devices.  During data 
collection, BP, HR, SpO2, end-tidal carbon dioxide tension (PetCO2), and minute ventilation were 
recorded continuously.  
3.2.2. CH Block 
 On each of 3 consecutive days, participants experienced one 60-minute exposure to 
hypoxia as follows: 1) Subjects initially breathed FIO2=21% (room air) for 10 minutes to achieve 
a steady state (as reflected by stable SpO2, PetCO2 and breathing pattern) and to collect baseline 
data. The subject then began to breathe FIO2~13.5% with subsequent adjustment in the same 
manner as during the IH block to achieve and maintain SpO2 at 80-90% for 60 minutes. Each day 
required approximately 3-4 hours of the participant’s time, including calibration, application and 
removal of the monitoring devices. BP, HR, SpO2, PetCO2 and minute ventilation were recorded 
continuously.  
3.2.3. Acclimatization Session  
 Participants breathed FIO2=21% (equivalent to room air) through the same facemask for 
60 minutes on one day. BP, HR, SpO2, PetCO2, and minute ventilation were continuously 
recorded. This day required approximately 3-4 hours of the participant’s time, including 
calibration, application and removal of the monitoring sensors. 
3.2.4. Washout  
There was > 1-week between the IH and CH blocks. The acclimatization session served to 
acclimatize subjects to the research procedure and was the first session in the series.  
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 3.3. Research Procedures  
3.3.1. Subject Instructions 
 
 Subjects were instructed not to eat or drink for at least 2 hours and to avoid food and 
beverages containing caffeine for 24 hours prior to arriving for each study block. They were 
asked to avoid meat, cured or smoked foods (e.g. ham, bacon, smoked fish) and leafy 
greens/vegetables (e.g. broccoli, kale, spinach) which may contain degraded red blood cells and 
or nitrates which may impact measured variables, for at least 48 hours before and during each 
study block. Participants were also asked avoid taking vitamin pills which may contain anti-
oxidants, for at least 3 weeks. Compliance with these requests was by self-report. Subjects were 
not permitted to eat or drink during the recording periods. However, they were permitted to drink 
water during the 2 hour interval between the end of the recording and the final blood sampling 
on day-3 of the IH and CH Blocks. 
3.3.2. Monitored Variables 
 
 SpO2 was recorded via finger pulse oximetry, HR and rhythm was recorded utilizing a 
modified EKG chest lead, BP was recorded utilizing commercially available device (PortapresR 
and ModelflowR software or Finapres®) using a cuff that was placed on a finger of the subject's 
non-dominant hand and inflated. The hand from which BP was recorded was supported at 
approximately the level of the left atrium during data collection. Breathing rate and pattern were 
recorded using respiratory inductance plethysmography (RIP) (Respitrace®). RIP is an 
established, non-invasive means to obtain semi-quantitative measures by recording chest wall 
movement via elastic bands that fit snugly around the rib cage and abdomen. The Respitrace® is 
calibrated by asking participants to breathe with a normal, stable rate and tidal volume (Vt) for 5 
minutes. A baseline average for breathing was established (in order to calculate subsequent tidal 
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 volume expressed as % baseline Vt). PetCO2 was measured utilizing a commercial infrared 
capnograph connected by or to a thin catheter placed within the facemask. The capnograph was 
calibrated daily before each session with gas containing a known amount of CO2. 
3.3.3. Gas Delivery 
 Subjects were semi-recumbent for 20 minutes prior to baseline data collection and during 
data collection periods. During each hypoxic exposure, subjects wore a commercially available 
partial rebreather or non-rebreather facemask (the same that is clinically used to deliver oxygen 
to patients) connected to a commercially available generator (Hypoxico, Inc.) which delivered 
gas at an adjustable FIO2. Guided by a published table (Hultgren, 1997), the generator was 
initially set to deliver an FIO2 = 13.5% and subsequently adjusted such that the subject’s 
SpO2=80-90%. Thereafter, the FIO2 was titrated as needed to maintain this SpO2 level by a 
dedicated member of the research team whose role was to constantly monitor participant status. 
During acclimatization sessions, subjects wore a facemask delivering room air.  
3.3.4. Blood Collection 
 
At each visit, measures of blood pressure (BP), heart rate (HR) and rhythm, arterial blood 
oxygen saturation (SpO2), end-tidal carbon dioxide tension (PetCO2), and breathing pattern data 
were obtained.  A subtotal of 90 cc of venous blood was obtained over each of the 3 days of 
Study Block 1 and Study Block 2.  20cc of blood were also obtained during the Acclimatization 
Block.  The grand total for all blood draws across all sessions was 200cc (see table below). 
Exhaled breath was sampled before and after each daily test session and analyzed for NO. The 
timing of blood draws was as follows: 10 cc of venous blood will be obtained by venipuncture 
for analysis of biomarkers of oxidative stress immediately prior to and after the last hypoxic 
exposure each day during the IH Block and CH Blocks. In addition, 15 cc of blood was drawn 
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 before the test run on day 1 and 2 hours after the test run on day 3 of the IH Block and CH Block 
to assess HIF-1α and iNOS mRNA.  All blood draws were done by an individual experienced in 
phlebotomy using standard venipuncture techniques. 
Table 1  Timing of blood collection 
 Control  CH  IH  Total
Day 1 Day 2 Day 3  Day 1 Day 2 Day 3   
Blood draws,
 in cc 
 20  35 20 35  35 20 35  200 
 
 
3.3.5. Exhaled  NO  
 Samples were obtained by having participants exhale from maximum to minimum lung 
volume at a constant flow rate into a gas analyzer (Logan Research, Kent, UK). Participants then 
breathed tidally for 4 minutes into a mixing chamber. A one-way valve was used to prevent 
rebreathing. Subjects wore wear a nose-clip during exhaled breath collection. 
3.3.6. Subject Distraction 
 To discourage participants from concentration on breathing which could influence the 
study variables, distraction was provided via television viewing or music. 
3.4. Setting and Sample 
 All data collection occurred in the Pulmonary Sleep Evaluation Lab at the University of 
Pittsburgh Medical Center.   
3.4.1. Entry Criteria 
 Healthy men between 18 and 45 years of age; able to speak and understand English;  
nonsmoker for at least three months; not on prescription medications.  
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 3.4.2. Exclusion Criteria 
 A history of cardiovascular disease (including but not limited to arrhythmia, syncope or 
near-syncope, systemic or pulmonary hypertension, angina pectoris, hyperlipidemia, congenital 
heart disease, primary family member with coronary artery disease). 
 A history of significant medical illness including thyroid abnormality, diabetes mellitus, 
pulmonary disease, or sleep-disordered breathing, neurologic disorder, anemia, sickle cell 
disease; 3) athlete in training; 4) obesity (body mass index >30); 5) history of high altitude 
illness, 6) resting SpO2 < 95%; 7) EKG consistent with coronary artery disease, right or left 
ventricular hypertrophy, or any dysrhythmia other than sinus arrhythmia; 8) PETCO2 ≥ 45 mm Hg 
at rest on room air; 9) spirometry indicating abnormal lung function indicated by % predicted 
values for forced vital capacity (FVC), forced expiratory volume at 1 second (FEV1), and/or 
FEV1/FVC ratio outside normal ranges for height, weight and sex.   
3.5. Limitations 
 Critical study variables (target SpO2, timing of IH and CH) were based on an extensive 
literature search and discussions with experts.  The proposed design had not been previously 
used and, while modeled on prior work, might have been insufficient stimulus to create the 
changes of interest. Notable cardiovascular sequelae do not develop in all who experience IH and 
it is possible that participants may not have been responsive to IH. However, prior studies 
investigating the effect of IH on ventilatory responsiveness (Garcia, Hopkins, & Powell, 2000; 
Katayama et al., 2001) and erythropoiesis (Garcia et al., 2000) in humans have demonstrated 
significance with < 9 subjects, suggesting this is unlikely. Subjects were healthy young males 
with no comorbidity, thereby excluding generalizability of results to a great number of 
individuals. However, it is hoped that study findings will be immensely valuable for the purpose 
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 of evaluating the study design and methodology in order to determine if a larger future study is 
justifiable. 
3.5.1. Sample Size Justification 
 Power analysis was performed using data from two studies using a similar design.  Arabi 
et al. (Arabi et al., 1999) examined HR and daytime BP elevation after nocturnal hypoxia in 10 
humans (DBP & SBP presented graphically, numeric data not provided).  Xie et al.(Xie et al., 
2000) examined neurocirculatory consequences of intermittent asphyxia in 7 humans. Both 
studies are similar to the proposed study in the cardiovascular variables examined and the 
interval of IH exposure, but not in regard to the timing of hypoxic exposure, as well as its multi-
day design. Published literature provided no examples of IH research using an identical design 
and methodology to the proposed study, including biomarker examination.  Given the nature of 
the proposed study,  results from Arabi et al. (Arabi et al., 1999) and Xie et al.(Xie et al., 2000) 
were judged most similar and used to determine a sample size that would result in a power of > 
0.80, with alpha set at 0.05 (See below). Based on this analysis, 12 subjects would appear 
adequate.  Sample size was set at 20 participants to allow for attrition and missing data. 
Table 2 Power analysis 
Study HR  Est. Sample Effect Size Power 
Xie et al. Baseline = 61 + 4 
Asphyxia = 64 + 4 
20 0.53 0.97 
Arabi et al. Normoxia = 61 + 9 
Hypoxia =   74 + 13 
10 0.83 0.96 
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 3.5.2. Data Analysis 
 Monitored variables were recorded continuously and downloaded to a computer. Mean 
values for SBP, DBP, HR, and SpO2 were analyzed for the first and last 10 minutes for control 
and CH blocks and for the first and last 2 minutes for the IH block.  Changes in breathing pattern 
and PETCO2 were analyzed descriptively and used as covariates. Preliminary analysis was 
conducted to: 1) compare measures of central tendency and dispersion; 2) examine distribution; 
and 3) plot and analyze residuals to detect nonlinear patterns and assure that statistical assumptions 
were met.   
3.5.2.1. Research Question 1 
Is there a difference in the impact of short-term exposure to IH versus CH on selected 
cardiovascular variables (SBP, DBP, and HR)?  
The last measurement of cardiovascular variables from each day’s IH session was 
compared with the same respective measurement of cardiovascular variables from the end of 
each day’s CH session by using repeated measures ANOVA to assess for changes over time. 
Differences in cardiovascular variables across measurement times for each day of IH exposure 
were examined using repeated measures ANOVA as well. 
3.5.2.2. Research Question 2 
 What is the effect of IH and CH on circulating and exhaled biomarkers of oxidative stress 
and HIF-1α activation (mRNA)? 
Values for exhaled biomarkers  of oxidative stress obtained prior to and after each day’s 
IH session were compared with the same respective measurements of exhaled biomarkers of 
oxidative stress obtained prior to and after each day’s CH session by using repeated measures 
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 ANOVA to assess for changes over time. The circulating marker for HIF-1α obtained before IH 
and CH session one, and after IH and CH session three, were also be examined using repeated 
measures ANOVA to assess for changes over time. 
3.5.2.3. Research Question 3 
 
 Is there a relationship between the increase in exhaled biomarkers of oxidative stress and 
HIF-1α activation (mRNA) and the change in SBP, DBP or HR?  
Linear regression analysis was utilized to examine the relationship between biomarkers 
(iNOS, HIF-1α, and oxidative stress) and cardiovascular parameters (SBP, DBP, and HR) 
measured at the end of the same respective IH and CH sessions. Pearson correlation coefficients 
between biomarkers and HR, SBP, and DBP changes were examined in each subject each day (in 
those measured each day) and over the course of each 3-day session. 
 The results of this study will be presented in the format of two manuscripts entitled 
IH versus CH: Impact on Hemodynamic Variables (Chapter 4) and IH versus CH: Relationship  
of Hemodynamic Response to Molecular Response (Chapter 5). 
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4. IH VS. CH: IMPACT ON HEMODYNAMIC VARIABLES 
4.1. Introduction 
  Intermittent exposure to hypoxia (intermittent hypoxia, IH) is common in the population. 
Obstructive Sleep Apnea (OSA), representing one temporal profile of IH secondary to upper 
airway obstruction during sleep, has been estimated to be present in 12-20 million people in the 
United States (Sieck, 2001). Acute and chronic cardiovascular alterations (Amin et al., 2004; 
Leung & Bradley, 2001; Neubauer, 2001; Prabhakar, 2002; Shahar et al., 2001; Silvestrini et al., 
2002), including systemic arterial hypertension and endothelial cell dysfunction (Fletcher, 2003; 
Lavie, 2003) have been associated with OSA. OSA, however, reflects a constellation of 
physiologic exposures including oxyhemoglobin desaturation-resaturation (IH), intermittent 
hypercapnia and central nervous system arousal. However, recent studies in animals suggest that 
the pattern of hypoxia (intermittent versus continuous) is important in determining the nature and 
magnitude of the physiologic response, with IH being a more potent stimulus than CH. Exposure 
of rats to IH is associated with augmented sympathetic nervous system activity and increases in 
blood pressure (BP) that are not seen following exposure to a comparable duration of CH in 
separate studies (Prabhakar, 2002; Young et al., 1997). Evidence from studies utilizing adult rats 
exposed to periods of IH for 8 hours per day for 30 (Greenberg et al., 1999) and 70 (Kraiczi et 
al., 1999) days also suggests that IH produces sustained BP increases and enhanced 
responsiveness of BP to short term hypoxia after long-term IH, respectively. 
 Studies in healthy humans (Cutler, Swift, Keller, Wasmund, & Smith, 2004; Xie et al., 
2000) have indicated that IH may augment sympathetic nerve activity (SNA) and BP.  Xie et 
al.(Xie et al., 2000) reported that even short-term IH exposure (20 seconds per minute of 
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 isocapnic hypoxia resulting in arterial blood oxygen saturation [SpO2] = 82 ± 1%, over 20 
minutes) augmented SNA in 7 healthy humans with SNA remaining elevated for at least 20 
minutes after return to baseline SpO2. In another IH study, Cutler et al. (Cutler et al., 2004) 
similarly observed that muscle sympathetic nerve activity (MSNA) and BP were increased 
during 20 minutes of intermittent voluntary “hypoxic apneas” (intermittent breath holding 
combined with breathing of mildly hypoxic air) in 7 healthy humans with MSNA, but not BP,  
remaining elevated during 180 minutes of recovery. However, numerous recent studies have 
hypothesized that alterations in the chemoreflex control of MSNA activity can influence the 
development of hypertension in patients with OSA (K Narkiewicz et al., 1999; Trzebski, 1992; 
Trzebski & Smietanowski, 1996).  
  Exploring a different profile of IH exposure, Arabi et al. (Arabi et al., 1999) indicated 
that exposure of 10 healthy normotensive subjects to 8-hours of hypobaric hypoxia (SpO2 = 
73±4%) on each of 2 consecutive nights with intervening normoxia was associated with diastolic 
BP (DBP) elevation that persisted after termination of hypoxic exposure. A recent study by 
Tamisier et al. (Tamisier, Anand, Nieto, Cunnington, & Weiss, 2005) is of particular relevance to 
the present study, as muscle SNA and hemodynamic response to IH and CH in normal humans 
was directly compared. This the only other instance that we are aware of where hemodynamic 
response to both IH and CH has been examined with the same subjects within the same study. 
Interestingly, Tamisier and co-workers found significant increases in BP and muscle SNA after 2 
hours of CH but not after 2 hours of  IH. 
The purpose of this study was to compare cardiovascular response to IH exposure on 
each of 3 consecutive days versus CH exposure on each of 3 consecutive days (with comparable 
daily hypoxic exposure time regardless of the exposure profile) in healthy subjects. We 
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 hypothesized that IH exposure would be associated with a greater increase in BP and/or HR from 
baseline to end-exposure on each day. We also hypothesized that augmentation of HR and/or BP 
would be greater with each IH exposure day compared with each CH exposure day. 
4.2. Methods 
4.2.1. Sample 
  Subjects were 10 healthy non-obese males aged 25.3 ± 5.7 years [mean + SD, range 20-
35 years, BMI < 30]. During screening, all subjects had resting SpO2 > 95%, resting end tidal 
carbon dioxide (PETCO2) < 45 mm Hg, and spirometry indicating normal lung function. The 
subjects were abstinent from tobacco smoking for at least 3 months, had no history of pulmonary 
or cardiovascular disease and were not on any prescription medications. All had normal 
electrocadiograms and none were in athletic training. Females were not eligible to participate due 
to the potential confounding effects of varying hormonal environments across the study interval. 
The study received approval from the University of Pittsburgh Institutional Review Board for 
Biomedical Research and all subjects provided written, informed consent. 
4.2.2. Procedure 
  Each subject participated in 3 exposure protocols: 1) normoxic acclimatization; 2) 3 
consecutive days of IH exposure; and 3) 3 consecutive days of CH exposure (Figure 3). The 
normoxic session acclimatized subjects to the procedure and was always the first in the series. 
Subjects were assigned to the IH or CH session based on their availability (in a non-randomized 
fashion); 4 subjects performed the IH protocol first and 6 performed the CH protocol first. To 
reduce the possibility of an interaction between the protocols, IH and CH sessions were 
separated by a washout period (≥ 7 days). 
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Figure 3 Scheme of normoxic and hypoxic exposures for the acclimatization session (60 minutes room air) IH 
session (6 hypoxic [FIO2 0.13.5] exposures for 10 minutes each) and CH session (one 60 minute hypoxic [FIO2 
0.13.5] exposure).   
 
  Subjects were semi-recumbent in a hospital bed for 15 minutes prior to and during data 
collection for the control, IH, and CH sessions. Distraction (television or music) was provided 
during all test sessions to discourage subjects from concentrating on their breathing, since this 
could influence study variables. Subjects could not be blinded to the nature of the exposure 
protocol, but were blinded to the hypothesis, as none of the subjects had advanced knowledge of 
hypoxia/cardiovascular physiology.  
4.2.2.1. Normoxic Acclimatization Protocol  
  Subjects breathed a fraction of inspired oxygen (FIO2) equal to 0.21 using a source of 
medical grade air [MGA]) through a commercially available non-rebreather facemask (also used 
for IH and CH sessions) for 60 minutes. The MGA was fed from a wall-mounted tap into a 15-
liter Douglas bag (also used during IH and CH sessions) which was connected to the mask worn 
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 by the subject via a one-way valve. Systolic, diastolic, and mean blood pressure (SBP, DBP, 
MBP), heart rate (HR), SpO2, and PetCO2 were continuously recorded for the first and last 5-
minute periods of the 60-minute session.  
4.2.2.2. IH Session  
  On each of 3 consecutive days, subjects were provided with 6 ten minute exposures to 
IH. Subjects initially breathed MGA through the non-rebreather facemask for 10 minutes to 
achieve a stable SpO2, PetCO2 and breathing pattern, after which baseline data were collected 
during 5 minutes of continuous recording. A FIO2 ~0.135 was then administered from a 
commercially available hypoxic gas generator (Hypoxico, Inc., New York, N.Y.) to the Douglas 
bag and facemask until the SpO2 was 80-90%. The hypoxic gas generator used in this study 
utilizes “pressure swing adsorption”, wherein zeolite crystals are used as a “molecular sieve”. 
The generator passes room air under pressure through a vessel containing an adsorbent bed (with 
zeolite crystals) that attracts oxygen more strongly than nitrogen such that gas coming out of the 
vessel is relatively enriched in nitrogen. SpO2 was maintained in this range with a target of 85% 
by bleeding in MGA as needed. After 10 minutes, the hypoxic exposure was ended and MGA 
was administered for 10 minutes. The same procedure was followed for a total of 6 IH 
exposures. Continuous recordings of SBP, DBP, MBP, HR, SpO2, and PetCO2 were obtained 
during the last 5-minutes of each day’s 6th IH exposure. 
4.2.2.3. CH Session  
  On each of 3 consecutive days, subjects had one 60-minute exposure to hypoxia. After 
initially breathing MGA through the non-rebreathing facemask for 10 minutes to achieve stable 
breathing, and then collecting baseline data for 5 minutes prior to the CH exposure interval, the 
FIO2 was adjusted to 0.135 in the same manner as during the IH session to achieve and maintain 
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 SpO2 at 80-90% for 60 minutes. Continuous recordings of SBP, DBP MBP, HR, SpO2, and 
PetCO2 were obtained during the last 5-minutes of each day’s CH exposure. 
4.2.2.4. Instrumentation  
   The SpO2 was monitored via finger pulse oximetry (CO2SMO Plus!® respiratory profile 
monitor, Novametrix Medical Systems, Inc., Wallingford, CT, USA). Heart rate and rhythm 
were monitored utilizing a standard 3-lead electrocardiogram (in lead 2). PetCO2 was obtained 
utilizing an infrared capnograph with a solid state mainstream flow sensor (CO2SMO Plus!® 
respiratory profile monitor) connected to the facemask. The CO2 sensor was calibrated daily 
before each session using internally generated values of 0 and 38 mmHg. SBP, DBP, and MBP 
were recorded using a Portapres® (Finapres Medical Systems, Amsterdam, Netherlands) via an 
inflated cuff placed on one or two fingers of the subject's non-dominant hand. The Portapres® was 
calibrated before each session with known pressures (0, 50, 100, and 150 mmHg) generated 
internally by the device and verified using a standard sphygmomanometer. Data were acquired and 
recorded using Labtech Notebook Pro software, version 10.1 (Andover, MA, USA). The 
recording channels for blood pressure, SpO2, and PetCO2 were calibrated with known values from 
the Portapres® and CO2SMO Plus!®.  
4.2.3. Data Analysis 
 Data are reported as the mean + standard deviation (SD). Statistical significance was set 
at p < 0.05 a priori. Cardiopulmonary parameters were analyzed by a 2 (IH vs. CH) x 3 (day 1, 
2, and 3) x 2 (baseline vs. end hypoxia) ANOVA. SPSS statistical package version 11.5 was used 
for analysis.  
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 4.3. Results 
  Values of all measured variables for baseline and end hypoxia during IH and CH 
sessions, reported as mean + SD, are reported in Table 3. 
Table 3 Hemodynamic values 
 SpO2 
(Percent) 
PetCO2 
(mmHg) 
HR 
(BPM) 
SBP  
(mmHg) 
DBP 
(mmHg) 
MBP 
(mmHg) 
IH 1 
Baseline 
End 
 
 
96.8+0.8 
85.0+2.3 
 
41.0+3.1 
39.3+2.6 
 
65.5+8.7 
77.6+8.6 
 
126.8+14.0 
134.2+17.0 
 
66.6+4.2 
71.3+11.8 
 
84.4+4.6 
87.5+11.8 
IH 2 
Baseline 
End 
 
 
97.0+1.3 
83.9+2.2 
 
41.7+2.4 
39.0+1.9 
 
65.0+5.6 
73.6+9.0 
 
128.7+14.5 
141.6+18.3 
 
67.6+9.2 
75.9+9.1 
 
85.5+10.3 
93.0+10.6 
IH 3 
Baseline 
End 
 
 
96.8+0.9 
84.3+1.8 
 
39.6+1.7 
38.1+1.5 
 
64.8+6.7 
73.4+5.9 
 
124.2+12.5 
136.3+14.5 
 
68.7+10.5 
75.0+9.4 
 
84.9+10.1 
90.7+10.0 
CH 1 
Baseline 
End 
 
 
97.0+1.0 
86.0+2.3 
 
39.5+4.2 
38.7+4.5 
 
64.0+9.6 
72.0+10.6 
 
131.5+16.3 
139.1+16.8 
 
74.4+8.0 
77.0+7.7 
 
91.6+9.0 
93.1+8.8 
CH 2 
Baseline 
End 
 
 
97.0+1.5 
86.3+2.8 
 
40.5+2.5 
39.3+2.3 
 
64.1+14.7 
74.2+9.2 
 
124.9+17.8 
131.2+14.3 
 
66.0+11.7 
69.2+8.7 
 
84.4+10.4 
87.1+6.7 
CH 3 
Baseline 
End 
 
96.4+3.4 
86.9+5.0 
 
 
38.2+3.2 
39.0+3.3 
 
68.3+8.5 
76.8+5.8 
 
123.8+13.0 
129.0+13.0 
 
69.9+11.3 
70.6+7.6 
 
87.3+8.4 
87.6+6.7 
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 4.3.1. Arterial Oxygen Saturation  
  The baseline SpO2 prior to all IH exposures was 96.9 + 0.1% and 84.4 + 0.5% during the 
last 5 minutes of all IH exposures. The baseline SpO2 prior to all CH exposures was 96.8 + 0.3% 
and 86.4 + 0.6% during the last 5 minutes of all CH exposures.  For the group, the SpO2 
decreased more from baseline during IH than during CH exposure (p = 0.01).  
4.3.2. End Tidal CO2  
  PetCO2 values are reported for 8 of the 10 subjects, due to technical problems.  The 
PetCO2 prior to and during the last 5 minutes of IH exposure were 40.8 + 1.1 mmHg and, 38.8 + 
0.6 mmHg, respectively. The PetCO2 prior to and during the last 5 minutes of CH exposure were 
39.4 + 1.2 mmHg and 38.9 + 0.3 mmHg, respectively.  The PetCO2 mean decreased more during 
IH than during CH from baseline to end exposure (p = 0.02, Figure 4).  
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 4.3.3. Heart Rate 
  When comparisons were made between data obtained at baseline and end exposure on 
each study day (e.g., IH-day 1, IH-day 2, IH-day 3), and each CH exposure (e.g., CH-day 1, CH-
day 2, and CH-day 3), there was a statistically significant (p <0.001) increase in HR, irrespective 
of exposure type (IH vs. CH) on day 1, day 2, and day 3 (Figure 5). The magnitude of the HR 
increase was not significantly different between the two exposure protocols. Thus, to summarize, 
HR increased from baseline to end exposure during both IH and CH, and the magnitude of the 
change was statistically similar in both exposure protocols.  
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4.3.4. Systolic Blood Pressure 
  When comparisons were made between data obtained at baseline and end exposure to IH-
day 1, IH-day 2, IH-day 3, and CH-day 1, CH-day 2, and CH-day 3, there was a statistically 
significant (p=0.009) increase in SBP, irrespective of exposure type (IH vs. CH) on day 1, day 2, 
and day 3 (Figure 6). The magnitude of the SBP increase was not significantly different between 
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 the two exposure protocols. Thus, SBP increased from baseline to end exposure during both IH 
and CH, and, as in the case of HR, the magnitude of the change was statistically similar in both 
exposure protocols. 
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Figure 6 Systolic blood pressure 
 
4.3.5. Diastolic Blood Pressure 
  When comparisons were made between data obtained at baseline and end exposure to IH-
day 1, IH-day 2, IH-day 3, and CH-day 1, CH-day 2, and CH-day 3, there was a statistically 
significant (p=0.02) increase in DBP, irrespective of exposure type (IH vs. CH) on day 1, day 2, 
and day 3 (Figure 7). The magnitude of the DBP increase was not significantly different between 
the two exposure protocols.  In summary, as with both HR and SBP, DBP increased from 
baseline to end exposure during both IH and CH, and the magnitude of the change was 
statistically similar in both exposure protocols. 
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Figure 7 Diastolic blood pressure 
4.4. Discussion 
 The main finding of our study was that, although the duration and degree of hypoxic 
exposure as reflected by the nadir SpO2 in our protocols was sufficient to elicit significant 
alterations of HR, SBP and DBP, the magnitude of these alterations did not change significantly 
over time (3 days) or differ by the hypoxia exposure profile.  
 Numerous studies have examined the hemodynamic response of humans to IH of 
different frequencies and durations (Arabi et al., 1999; Cutler et al., 2004; Morgan, Crabtree, 
Palta, & Skatrud, 1995; Xie, Skatrud, Puleo, & Morgan, 2001; Xie et al., 2000), and a lesser 
number have examined sympathetic and hemodynamic response to CH of days to weeks in 
duration (Calbet, 2003; Hansen & Sander, 2003). However, to the best of our knowledge, only 
one other study has directly compared hemodynamic responses to IH and CH in humans 
(Tamisier et al., 2005). While the Tamisier et al. (Tamisier et al., 2005) investigation exposed 
subjects to IH and CH once for 2 hours each on separate days ~1 month apart, our study had the 
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 capability to look for hemodynamic changes over the course of 3 consecutive days of IH and CH 
exposures. 
  Changes (elicited by hypoxia) in the physiologic parameters measured in this study, over 
the course of days, have been of interest for some time. Some of the hemodynamic changes that 
occur during the IH episodes of OSA are thought to persist into the waking hours, causing e.g., 
daytime systemic hypertension (Fletcher, 2003).  This “carryover”, or long term facilitation 
(LTF) with potentiation of SNA outflow, may be dependent on prior hypoxic stimulation. Xie et 
al. (Xie et al., 2001) has speculated that this memory-like effect occurs in neurons of the rostral 
ventrolateral medulla (RVLM), is related to a modulation of afferent input from peripheral 
chemoreceptors  by brain hypoxia , and is responsible for generating sympathetic “tone”. Peng et 
al. (Peng, Overholt, Kline, Kumar, & Prabhakar, 2003) recently demonstrated  that LTF of 
carotid body sensory discharge (in the form of progressive baseline sensory activity) increases 
with each successive hypoxic challenge, persisting for at least 60 min., in rats exposed to 
“chronic” IH (15 sec. of FIO2 = 0.05 followed by 5 min. normoxia, 9 episodes/hr., 8 hr./day for 
10 days) when given “acute” IH challenges (10 episodes of 15 sec. Of 12% O2 interspersed with 
5 min. of 95% O2), but not in animals exposed to CH (FIO2 = 0.05 for 4 hrs.) for 10 days in either 
acute or multiple exposures when given the “acute” IH challenge.  
  Aside from the issue of LTF, it must be noted that there is disagreement as to the duration 
of IH necessary to evoke a hemodynamic response. For example, Fletcher et al. found an 
elevated arterial pressure in rats after 35 days of 8 hr./day nighttime hypoxic exposure, but not 
after 10 days (Fletcher et al., 1992). By contrast, Sica et al. (Sica, Greenberg, Ruggiero, & 
Scharf, 2000) and Peng et al.(Peng et al., 2003) found that systolic arterial pressure increases in 
rats after 7 days of chronic IH with a pattern like that used by Fletcher et al. It should also be 
36 
 noted that when SNA remains elevated during recovery from hypoxia exposure, there is no 
certainty that BP will remain elevated. Why BP is not elevated in some cases when sympathetic 
vasoconstrictor outflow remains elevated is unknown, but Xie et al.(Xie et al., 2001) suggest that 
the magnitude of sympathoexcitation after 20 minutes of hypoxic exposure may not be sufficient 
to alter total peripheral resistance. They suggest that longer periods of hypoxic exposure are 
likely needed to activate mechanisms such as the renin-angiotensin axis.  
  Adding to the debate regarding the pattern and duration of hypoxia necessary to evoke a 
hemodynamic and/or a SNA response, Tamisier et al. (Tamisier et al., 2005) has recently found 
that in 10 healthy  humans, BP and muscle SNA actually show a statistically significant (p<0.05) 
increase after 2 hours of CH but not 2 hours of  IH. In this study, IH was induced by alternating 
breathing of 100% nitrogen and room air so as to produce 30 to 40 drops in SpO2 per hour (with 
10% fluctuation in SpO2, nadir = SpO2 of 85%). These findings support the speculation that 
hemodynamic and SNA response to hypoxia depends more on the intensity of exposure than 
pattern of exposure, as subjects in the Tamisier et al. study exhibited significantly more profound 
hypoxia during 2 hrs. of CH than during 2 hrs. of IH (SpO2 of 85.1 +1.6% for CH vs. 92.0 + 
3.4% for IH; p<0.001).  Even though the reported range between the maximum and nadir SpO2 
was greater during IH (93.8 + 2.7 and 67.9 + 6.8%) compared with CH (98.8 + 1.1 and 75.0 + 
4.5%), CH still elicited a significantly greater hemodynamic and SNA response than IH. The 
results of our study provide a contrast to the results of the work by Tamisier et al. We found that 
the average SpO2 during the last 5 minutes of all IH exposures was 84.4 + 0.5%, and the average 
SpO2 during the last 5 minutes of all CH exposures was 86.4 + 0.6%, but we cannot go beyond 
saying the SpO2 was in the 80-90% range (with a target of 85%) during the preceding minutes of 
the IH and CH exposures. As such, it is impossible for us to accurately speculate on the actual 
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 difference in SpO2 magnitude between IH and CH during all of the study’s hypoxia exposure 
times. However, we did find that 60 minutes of CH with the SpO2 in the 80-90% range prompted 
a statistically similar hemodynamic response to six 10 minute IH exposures with SpO2 in the 80-
90% range, while Tamisier and coworkers found that 2 hours of much more frequent IH than 
ours did not evoke statistically similar hemodynamic results compared to 2 hours of CH. It is 
possible that the more profound differences in hypoxia levels reported during Tamisier et al.’s IH 
and CH exposures may account for this difference in response between our studies, but it is 
conceivable that other aspects of our study design (e.g., IH frequency and IH/CH duration) may  
have accounted for the similar hemodynamic response to IH and CH (Brooks et al., 1997).  
  Hence, there are several factors that should be considered when interpreting our data. 
While current thinking suggests the mechanism of increase in BP is related to activation of the 
sympathetic nervous system and concurrent activation of the renin-angiotensin system (Fletcher, 
Bao, & Li, 1999), the duration and/or frequency of IH necessary for BP alteration in humans is 
not known. This may be an important factor in considering why no statistically significant 
difference in day-to-day BP changes during the 3-day IH and CH sessions was noted in the 
present study. Perhaps the duration and/or frequency of IH and CH exposures in this study was 
not sufficient to sustain a significant day-to day activation of the sympathetic nervous system and 
the renin-angiotensin system. It is, however, worth noting that during IH exposures, SBP and 
DBP (Figs. 6 and 7) show a tendency (although not a statistically significant tendency) to 
increase over the course of the 3-day session – especially from day 1 to day 2. Additionally, it 
appears that in our study IH may have possibly created a more profound ventilatory stimulus, 
with a statistically significant baseline to end change in PetCO2 (in IH as compared to CH), 
during the last 5 minutes of each day’s IH and CH exposures (Figure 2). It is not known if this 
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 greater baseline to end exposure change persisted throughout the entirety of the IH sessions, but 
if it did, lower CO2 levels during IH may possibly have influenced SNA and hemodynamic 
response. 
  It is possible that although sufficient to alter hemodynamic variables, the nature of the IH 
and CH profiles used our study may not have been sufficiently different and/or the sample size 
may have been too small to elicit detectable differences in hemodynamic responses. It is 
intriguing to speculate as to what change in the design and methodology of this study might be 
sufficient to cause a statistically significant difference in HR or BP change between IH and CH 
blocks or between days of exposure within each block. The 10-minute duration of IH exposures 
used in this study does not accurately simulate the character of the hypoxic episodes caused by 
the obstructive apneas seen in OSA. It is likely that voluntary apneas (creating a level of 
hypercapnia) lasting, e.g., ~30 seconds every 1 minute --simulating an apnea/hypopnea index of 
60/hour - for 20 minutes as performed by the Cutler et al. study participants (Cutler et al., 2004), 
perhaps in combination with continuous breathing of mildly hypoxic air, may conceivably be the 
most effective way in which to simulate OSA for research purposes with human subjects. 
However, that it is unlikely that an experimental protocol has yet been designed, for animals or 
humans, to accurately simulate all of the characteristics of OSA (e.g., the Cutler et al. study 
ignores the potential interaction with sleep and arousal). Although the intent of the protocols in 
this study was not to mimic the episodes of hypoxic apnea characteristic of OSA, we nonetheless 
aimed to create an effective method with which it would be possible to explore the hemodynamic 
response to variations in the duration/frequency of hypoxia exposure in normal human subjects. 
 In summary, the results of this study provide insight into the potential design of future 
studies aiming to elucidate the mechanisms responsible for pathophysiologic changes in humans 
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 suffering from hypoxia-related diseases. While inconsistent findings across studies reported to 
date may be due to differences in, e.g., experimental protocol and sample size, future studies 
directly comparing hemodynamic and SNA response to IH and CH will need to carefully 
consider how to match two different patterns of hypoxia. We chose to match the total duration of 
exposure and (attempted) to match the nadir of SpO2. Further work in this area will help 
investigators better understand whether the sympathetic/hemodynamic response during and 
following hypoxia depends more on the mean SpO2 value, total duration, or pattern of hypoxic 
exposure. 
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5. IH VS. CH: RELATIONSHIP OF HEMODYNAMIC RESPONSE TO 
MOLECULAR RESPONSE 
5.1. Introduction 
 Exposure to hypoxia triggers a spectrum of biologic (cellular) and physiologic (organ 
system) responses. Alterations in cardiovascular parameters such as blood pressure (BP) and 
heart rate (HR) reflect one physiologic change that is modulated by central and peripheral 
chemoreceptors.  Hypoxia Inducible Factor 1α (HIF-1α) represents a consequence at the cellular 
level. While difficult to detect  under normoxic conditions because of a normoxic half-life of less 
than 5 minutes (Huang, Arany, Livingston, & Bunn, 1996; Wang, Jiang, Rue, & Semenza, 
1995), HIF-1α “increases” as oxygen tension decreases because hypoxia slows destruction of 
HIF-1α (Huang & Bunn, 2003).  HIF-1α has been called the most important protein regulating 
molecular response to hypoxia in mammals (Hopfl, Ogunshola, & Gassmann, 2003). As a 
transcription factor, HIF-1α activates a number of genes associated with hypoxic adaptation, 
including several genes important to vascular function such as vascular endothelial growth factor 
(VEGF), erythropoietin (EPO), and inducible nitric oxide synthase (iNOS)  (G. Semenza, 2000). 
Nitric oxide (NO) is produced through the action of three isoforms of nitric oxide synthase 
(NOS); endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS) (Isaacson, 
Hampl, Weir, Nelson, & Archer, 1994; Le Cras et al., 1998; Le Cras, Xue, Rengasamy, & Johns, 
1996; Muramatsu, Tyler, Rodman, & McMurtry, 1996; L. A. Palmer, Semenza, Stoler, & Johns, 
1998; Resta, Gonzales, Dail, Sanders, & Walker, 1997; Resta & Walker, 1996; Russ & Walker, 
1992; Shaul, Kinane, Farrar, Buja, & Magness, 1991; Wilson, Thompson, Moore, Khimenko, & 
Taylor, 1997; Xue & Johns, 1996). 
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   Ni et al. (Ni, Bemanian, Kivlighn, & Vaziri, 1998) has reported that a hypoxia-induced 
increase in BP is accompanied by a marked reduction in urinary excretion of nitric oxide (NO) 
metabolites in a rat model. This suggests that hypertension induced by chronic exposure to 
hypoxia in the rat is associated with, and possibly due to, decreased NO availability. NO has 
many properties among which is as a potent mediator of vasodilation (Ignarro, Buga, Wood, 
Byrns, & Chaudhuri, 1987; R. M. J. Palmer, Ferrige, & Moncada, 1987). The observation that 
iNOS is upregulated (e.g. increased mRNA expression and iNOS protein ) within the pulmonary 
vasculature in rats (Le Cras et al., 1998; Le Cras et al., 1996; L. A. Palmer et al., 1998; Shaul et 
al., 1995; Xue & Johns, 1996) with chronic hypoxic exposure has prompted speculation that  it 
blunts hypoxic vasoconstriction in the pulmonary and other arterial beds (Resta, O'Donaughy, 
Earley, Chicoine, & Walker, 1999) by opposing the vasoconstrictor effects of endothelin, 
angiotensin II, and renal  sympathetic nerve activity (Kone, 1997; Kone & Baylis, 1997). In 
addition, the presence of NOS in the bronchial epithelium confirms a potential distinct source of 
NO production outside of the vasculature (Kobzik et al., 1993; Pearl et al., 2000).  
  There is inconsistent evidence supporting the thinking that the pattern of hypoxia 
(intermittent [IH] or continuous [CH]) is a significant factor in determining physiologic 
response. For instance, a recent study by Tamisier et al. (Tamisier et al., 2005) reported that in 10 
healthy humans, BP and muscle sympathetic nerve activity (SNA) actually show a statistically 
significant (p<0.05) increase after 2 hours of CH but not 2 hours of  IH. However, another study 
in humans failed to demonstrate different effects of IH and CH on hemodynamic variables 
(Rodway et al., 2005). On the other hand, animal studies have shown marked increases in BP and 
sympathetic activity following IH that are not seen following exposure to a similar duration of 
CH (Prabhakar, 2002; Young et al., 1997). 
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 The purpose of this study was to explore the relation between the hemodynamic and 
molecular responses in normal human subjects who were exposed to 2 profiles of hypoxia, IH 
and CH.  Attempting to identify the relationship between molecular and hemodynamic responses 
may help to provide a better understanding of inter-individual differences in physiologic 
response of human subjects to different patterns of hypoxic stimulus. 
5.2. Methods 
5.2.1. Sample 
  Data were collected on 10 healthy males aged 25.3 ± 5.7 years (mean + SD, range 20-35 
years) as part of a study of the hemodynamic responses to IH and CH, described in chapter 4 of 
this report. Characteristics of participants are described there in more detail.  In brief, none of the 
subjects had smoked for > 3 months; were taking prescription medications; or engaged in a 
formal athletic training program. None of the subjects had a history of cardiopulmonary disease 
and all had a resting room air SpO2 >95%, a normal electrocardiogram, and normal spirometry. 
Only males were studied to avoid the potentially confounding influence of cyclic estrogen and 
progesterone fluctuation on study variables.  The study received approval from the University of 
Pittsburgh Institutional Review Board for Biomedical Research and all subjects provided written, 
informed consent. 
5.2.2. Procedure 
 Subjects were instructed not to eat or drink for at least 2 hours and to avoid food and 
beverages containing caffeine for 24 hours prior to arriving for each study block. They were also 
asked to avoid meat, cured or smoked foods (e.g. ham, bacon, smoked fish) and leafy 
greens/vegetables (e.g. broccoli, kale, spinach) which may have contained degraded red blood 
cells and or nitrates for at least 48 hours before and during each study block. In addition, 
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 participants were asked to avoid taking vitamin pills which may have contained anti-oxidants for 
at least 3 weeks. Compliance with these requests was by self-report. 
   The protocol for IH and CH has been described in chapter 4 and is reported briefly here: 
each subject participated in 3 sessions: 1) normoxic acclimatization; 2) 3 consecutive days of IH; 
and 3) 3 consecutive days of CH (Figure 3).  Four subjects started with the IH session and 6 with 
the CH session. To eliminate an order effect, IH and CH sessions were separated by a washout 
period (≥ 7 days).  During all sessions, subjects were semi-recumbent in a hospital bed for 15 
minutes prior to and during data collection. Since subject’s concentration on their breathing 
could potentially influence study variables, distraction in the form of television or music was 
provided during all test sessions.  Subjects could not be blinded to the nature of the exposure 
protocol, but were blinded to the hypothesis, as none of the subjects had advanced knowledge of 
hypoxia/cardiovascular physiology.  
5.2.2.1. Normoxic Acclimatization Session  
    Subjects breathed medical grade air (MGA) through a commercially available non-
rebreather anesthesia facemask for 60 minutes. The mask worn by the subject was connected via 
a one-way valve to a 15-liter Douglas bag, out of which ran a line connected to a wall-mounted 
tap supplying the MGA. For the first and last 5-minute period of the 60-minute session, systolic, 
diastolic, and mean blood pressure (SBP, DBP, MBP), heart rate (HR), SpO2, and PetCO2 were 
continuously recorded. 
5.2.2.2. IH Session  
 Subjects underwent 6 exposures to IH on each of 3 consecutive days. In order to achieve a 
steady state (as reflected by stable SpO2, PetCO2 and breathing pattern) and collect baseline 
hemodynamic data, MGA was administered to subjects for 10 minutes through the identical non-
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 rebreather facemask used in the normoxic acclimatization session. Data were recorded 
continuously for 5 minutes immediately before initiating IH exposure. A commercially available 
hypoxia generator (Hypoxico, Inc., New York, N.Y.) utilizing “pressure swing adsorption”, with 
zeolite crystals used as a “molecular sieve”, fed hypoxic air (FIO2 ~0.135) to the Douglas bag 
and hence to the non-rebreather facemask until the subject’s SpO2 was 80-90%. The same 
research team member who monitored subject status also maintained the SpO2 in this range, with 
a target of 85%, by bleeding in MGA as needed. After 10 minutes of SpO2 80-90%, the IH 
exposure ended and MGA was administered so that SpO2 > 90% for 10 minutes. A total of 6 IH 
exposures were given in this manner during each of the 3 days. Hemodynamic variables were 
then recorded continuously during the last 5-minutes of each day’s 6th IH exposure. 
5.2.2.3. CH Session  
   Subjects underwent one continuous 60-minute exposure to hypoxia on each of 3 
consecutive days. In order to achieve a steady state (as reflected by stable SpO2, PetCO2 and 
breathing pattern) and collect baseline hemodynamic data, MGA was administered to subjects 
for 10 minutes through the identical non-rebreather facemask used in the control and IH session. 
Data were recorded continuously for 5 minutes immediately before initiating CH exposure.  The 
hypoxia generator then began to feed air (FIO2 ~0.135) to the Douglas bag and hence to the non-
rebreather facemask in the same manner as during the IH session until the subject’s SpO2 was 80-
90%. The subject’s SpO2 was maintained in this range for 60 minutes, with a target of  85%, by 
bleeding in MGA as needed. During the last 5-minutes of each day’s CH session, hemodynamic 
variables were recorded continuously. 
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 5.2.2.4. Instrumentation  
 A standard 3-lead electrocardiogram (in lead 2) was used to monitor heart rate and rhythm. 
Finger pulse oximetry was used to measure SpO2 (CO2SMO Plus!® respiratory profile monitor, 
Novametrix Medical Systems, Inc., Wallingford, CT, USA). A commercial infrared capnograph 
with a solid state mainstream flow sensor (CO2SMO Plus!® respiratory profile monitor), 
connected to the non-rebreather facemask, measured PetCO2. Before each session, The CO2 
sensor was calibrated using internally generated values of 0 and 38 mmHg. An inflated cuff 
placed on one or two fingers of the subject's non-dominant hand recorded SBP, DBP, and MBP 
(Portapres®, Finapres Medical Systems, Amsterdam, Netherlands). Known pressures (0, 50, 100, 
and 150 mmHg), generated internally by the device and verified using a standard 
sphygmomanometer, were used to calibrate the Portapres® before each session. The recording 
channels for blood pressure, SpO2, and PetCO2 were calibrated with known values from the 
Portapres® and CO2SMO Plus!®. Labtech Notebook Pro software, version 10.1 (Andover, MA, 
USA), was used for data acquisition. 
5.2.2.5. Blood Collection and iNOS/ HIF-1α mRNA Analysis 
 Venous blood was obtained prior to hypoxic exposure on day 1 of IH and CH of each 
study block and 2 hours after the end of the hypoxic exposure on day 3 of the IH and CH study 
blocks, for HIF-1α and iNOS mRNA gene expression analysis (Table 4).  
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 Table 4 Blood collection time points 
 
  IH / CH
 Day 1 Day 2 Day 3 
         Pre-hypoxia 
2 hrs. post-hypoxia 
X   
X 
 
PAXgene Blood RNA Tubes were used for blood collection and cellular RNA stabilization, and 
the PAXgene Blood RNA Kit was used for isolation of cellular RNA (PreAnalytiX; 
Hombrechtikon, Switerland). Gene expression quantification was performed in a two-step 
reverse transcription-polymerase chain reaction (RT-PCR) in which the PCR step is coupled with 
a 5’ fluorogenic nuclease assay to amplify target cDNA without amplifying genomic DNA. In 
the reverse transcription (RT) step, cDNA is reverse transcribed from total RNA samples using 
random primers from a High Capacity cDNA Archive Kit (Applied Biosystems; Foster City, 
California USA). In the PCR step, PCR products are synthesized from cDNA samples using 
TaqMan Universal PCR Master Mix (Applied Biosystems; Foster City, California USA). 
Assays-on-Demand (Applied Biosystems; Foster City, California USA) were utilized for 
detection and quantitfication of nucleic acid sequences via ready-to-use 5’ nuclease assays for 
human transcripts. The primer sequence for the 5’ iNOS nuclease assay was 
CATAGTTTCCAGAAGCAGAATGTGA, and the primer sequence for the 5’ HIF-1α nuclease 
assay was ACACACAGAAATGGCCTTGTGAAAA. Human glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was utilized as an external control assay in separate wells from the 
target assay in the 96-well PCR reaction plate. Relative quantification of gene expression was 
accomplished via the comparative count (CT) method, taking into account that the efficiency of 
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 the target and GAPDH amplification was nearly identical for a given amount of cDNA (slope of 
log input amount vs. normalized value <0.1). The normalized amount of target is a unitless 
number used to compare the relative amount of target in different samples, and is determined by 
dividing the average target value by the GAPDH value. The instrument used for data collection 
was an Applied Biosystems 7000 Sequence Detection System (Applied Biosystems; Foster City, 
California USA). 
5.2.3. Data Analysis 
 Data are reported as the mean + standard deviation. Statistical significance was 
considered at p< 0.05. SPSS statistical package version 11.5 was used for analysis. 
Nonparametric correlation coefficients (Spearman’s rho) were examined in order to determine 
the relationship between the hemodynamic and molecular parameters. Because this study 
involved a small number of subjects and thus a normal distribution of values could not be 
assumed, Spearman’s was utilized for the correlation analysis, rather than its parametric 
counterpart.   
5.3. Results 
Molecular data were available in 9 subjects (samples for one subject were unusable for 
analysis). The mean of the 3 days of baseline IH and CH hemodynamic values were correlated 
with the baseline IH and CH molecular values, and the mean of the 3 days of end IH and CH 
hemodynamic values were correlated with the end IH and CH molecular values. Nonparametric 
correlation coefficients for the relation between hemodynamic variables and  iNOS mRNAare 
presented in Table 5. There were significant correlations between iNOS mRNAand DBP (r = -
0.89, p < 0.01, Figure 8) and MBP (r = -0.87,  p < 0.01, Figure 9), but not SBP (r = -0.61, p=NS, 
Figure 10) at the end of the day 3 IH session.  The range of r values for iNOS mRNA/ BP 
48 
 correlation prior to day 1 IH session was -0.24 to -0.07, and none of the values were statistically 
significant.  
Table 5 iNOS / hemodynamic nonparametric correlation coefficients. Nonparametric correlation coefficients 
for n=9. ** Correlation is significant at p<.01 level 
 
 IH 1 IH 3 CH 1 CH 3 
 
etCO2
 
-.54 
 
-.30 
 
-.27 
 
-.25 
  
 
   
HR .24 -.35 -.42 -.27 
  
 
   
SBP -.07 -.61 .33 .15 
  
 
   
DBP -.24 -.89 ** -.04 .12 
  
 
   
MBP -.10 -.87** .12 .43 
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 Intermittent Hypoxia iNOS/DBP Relationship
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Figure 8 Plot of iNOS / Diastolic BP Relationship; IH1 r = -0.24, p = NS; 2 hour post IH3 r = -0.89, p<0.01. 
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 Intermittent Hypoxia iNOS/MBP  Relationship
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Figure 9 Plot of iNOS / Mean BP Relationship; IH1 r = -0.10 p = NS; 2 hour post IH3 r = -0.87, p<0.01. 
 
Intermittent Hypoxia iNOS/SBP Relationship
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Figure 10 Plot of iNOS / Systolic BP Relationship; IH1 r = -0.07, p = NS; 2 hour post IH3 r = -0.61, p = NS. 
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 The range of r values for iNOS mRNA/ BP correlation was -0.04 to 0.33 before CH, and 
0.12 to 0.43 after CH; none of these values were statistically significant (see Figures 11 - 13 for 
correlations of iNOS mRNA with DBP, MBP, and SBP for CH, respectively).  No other 
statistically significant correlations were seen between hemodynamic variables and iNOS mRNA 
before or after IH or CH. 
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Figure 11 Plot of iNOS / Diastolic BP Relationship; CH1 r = -0.04, p = NS; 2 hour post CH3 r = 0.12, p = NS. 
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Figure 12 Plot of iNOS / Mean BP Relationship; CH1 r = 0.12, p = NS; 2 hour post CH3 r = 0.43, p = NS. 
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Figure 13 Plot of iNOS / Systolic BP Relationship; CH1 r = 0.33, p = NS; 2 hour post CH3 r = 0.15, p = NS. 
 
A significant correlation involving HIF-1α mRNA was noted only for PetCO2  at the end 
of the day 3 CH session (r = -0.68, p<0.05, Table 6). Before IH, the range of r values for HIF-1α 
mRNA/ BP correlation was -0.39 to -0.31, and after IH, -0.06 to 0.10. The range of r values for 
HIF-1α mRNA/ BP correlation was -0.32 to 0.0 before CH, and -0.07 to 0.26 after CH.  None of 
these correlation values were statistically significant. No other statistically significant 
correlations were seen between hemodynamic variables and HIF-1α mRNA before or after IH or 
CH. 
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 Table 6 HIF-1α / hemodynamic nonparametric correlation coefficients. Nonparametric correlation 
coefficients for n=9. * Correlation is significant p<.05 level. 
 
 IH 1 IH 3 CH 1 CH 3 
 
etCO2      
 
 
-.36 
 
-.15 
 
.05 
 
-.68* 
     
HR   
     
-.09 .02 -.55 .04 
     
SBP     
 
-.33 .10 .00 .12 
     
DBP    
 
-.39 -.04 -.32 -.07 
     
MBP    -.31 -.06 -.14 .26 
     
 
 
 
 
 
 
 
 
5.4. Discussion 
 Our results show a significant negative correlation (p<0.01) of iNOS mRNA with DBP 
and MBP after the third day of IH. It is conceivable that in our study the IH stimulus may have 
been potent enough to influence iNOS expression, at least as far as the relationship to DBP and 
MBP response was concerned. Hence, it follows that the stimulus from CH may not have been 
strong enough to influence iNOS expression as a mediator of vascular response. We found that 
the average SpO2 during the last 5 minutes of all IH exposures was 84.4 + 0.5%, and the average 
SpO2 during the last 5 minutes of all CH exposures was 86.4 + 0.6%, but we cannot go beyond 
saying (in regard to the magnitude of hypoxia) that during the preceding minutes of the IH and 
CH exposures the SpO2 was in the 80-90% range (with a target of 85%). It is thus not possible for 
us to speculate as to the actual difference in SpO2  between IH and CH during all of the study’s 
hypoxia exposure times. We can, however, indicate that the total hypoxic time (time of IH SpO2 
< 90% compared to CH SpO2 < 90%) was, by design, identical. Although the results of this study 
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 may provide some support the thinking that IH is a more potent physiological stress than CH in 
regard to iNOS expression and its mediation of BP, important questions remain.   
 Why this same relationship with BP was not seen in the case of HIF-1α may be due in 
large part to the study design. The timing of blood collection for analyzing gene expression may 
have accounted for the results. Venous blood was obtained immediately prior  to the  start of the 
exposure protocol on day 1 of IH and CH, as well as 2 hours after the end of IH and CH on day 
3, for HIF-1α and iNOS mRNA analysis. Transcriptional activation of iNOS by HIF-1α 
presumably occurred at some time prior to the collection of blood 2 hours after the end of IH and 
CH on day 3, but nonetheless, an up-or-down regulated  HIF-1α response to hypoxia would have 
been virtually impossible to detect after 2 hours of normoxia because of HIF-1α’s normoxic 
half-life of less than 5 minutes (Huang et al., 1996; Wang et al., 1995), Additionally, the gap in 
HIF-1α and iNOS mRNA data points between day 1 baseline of IH and CH and 2 hours post IH 
and CH on day 3 makes speculation as to a time sequence for expression rather difficult.  
Collection of blood immediately before and immediately after each day of IH and CH may have 
provided enough data to increase the confidence of such speculation.    
 Our results are both suportive of, and in conflict with, other investigations of the reponse 
to IH and CH.  Barton et al. (Barton, Zhenmin, & Vaziri, 2003) reported that chronic hypoxia-
induced hypertension in rats is associated with marked downregulation of NOS isotypes over the 
course of 21 days. Their data demonstrated a consistent pattern of early increase (within 48 to 72 
hours) followed by a steady decline in iNOS in the kidney and cardiovascular tissues during 
exposure to hypoxia. There is also some suggestion that hypoxia impairs the output of 
endongenous NO (Haight & Djupesland, 2003). Haight & Qian (Haight & Qian, 2000) found 
that changes in blood oxygen levels, achieved either through breath-hold or by lowering the 
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 oxygen content of the gas flowing through the nose while the subject mouth breathes, quickly 
lowers exhaled NO output (but the inevitable washout of nasal NO with this method may 
influence the results). Other studies have suggested that in patients with obstructive sleep apnea 
(OSA), circulating NO reduction may be due to impaired function of the vascular endothelial 
cells (Ip et al., 2000; Kato et al., 2000; Schulz et al., 2000). Ip et al. (Ip et al., 2000) and Schulz et 
al.(Schulz et al., 2000) found that CPAP reversed the suppression of NO output in OSA, 
supporting the the view that hypoxia is responsible for depressed NO synthesis in these patients 
(McQuillan, Leung, Marsden, Kostyk, & Kourembanas, 1994). Furthermore, the realtionship of  
HIF-1α to iNOS and synthesis of NO is not completely understood. However, a study by Yin et 
al. (Yin, Yang, Ku, & Hsu, 2000) demonstrated that NO generated by iNOS expression inhibits 
HIF-1α DNA binding activity in a hypoxic cell culture, suggesting a possible negative feedback 
loop in the HIF-1α/iNOS cascade. 
  Hypoxic regulation of iNOS in humans is a phenomenon about which relatively little is 
known (Pitt & St. Croix, 2002). In contrast to the thinking that hypoxia is responsible for 
depressed NO synthesis in the above-mentioned studies, elevation of iNOS was found in cardiac 
biopsies in cyanotic children with congenital heart disease (Ferreiro et al., 2001). Dweik et al. 
(Dweik et al., 1998) provided support for iNOS as a mediator of vascular response to oxygen in a 
study of the effect of hypoxia on NO production in normal human volunteers. Likewise, exhaled 
NO is elevated in healthy high altitude natives living in Tibet and Bolivia, compared to normals 
at or near sea level (Beall et al., 2001). A decrease in exhaled NO is seen in sojourners to high 
altitude known to be susceptible to high altitude pulmonary edema (HAPE), but not in HAPE-
resistent sojourners (Busch et al., 2001). These studies suggest that changes in NO production 
induced by hypoxia may be a homeostatic response helping to maintain a low vascular resistance 
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 during such a stimulus (Pitt & St. Croix, 2002), and our findings seem to support this thinking. 
Hypoxia seems to be an important factor in the elevation or depression of iNOS and NO. 
However, given the lack of consensus among studies, it is conceivable that the frequency, 
duration and intensity of hypoxic stress is influential in regulating NO in ways that has yet to be 
fully elucidated.  
  It is possible that HIF-1α may also play a significant role in inter-individual variability in 
cardiovascular responses to hypoxia. The development of pulmonary artery hypertension and 
pulmonary artery medial hypertrophy with hypoxic exposure are thought to be influenced by 
HIF-1α (G. L. Semenza, 2001). Mice experienced delayed development of pulmonary artery 
hypertension and right ventricular (RV) hypertrophy during CH exposure when the gene 
encoding for HIF-1α was inactivated (G. Semenza, 2000; G. L. Semenza, 2001; Yu et al., 1999). 
Analysis of knockout mice has also demonstrated that HIF-1α is required for embryonic 
development and survival. Conversely, mice that are heterozygous for the knockout allele, and 
thus partially HIF-1α deficient, develop normally (G. L. Semenza, 2001). Yu et al.(Yu et al., 
1999) compared the physiological response of partially HIF-1α deficient heterozygous mice to 
the response of their normal (wild-type) littermates after breathing 10% oxygen for 1 to 6 weeks. 
The partially HIF-1α deficient heterozygous mice demonstrated significantly delayed 
development of polycythemia, RV hypertrophy, pulmonary hypertension, and pulmonary 
vascular remodeling compared with their normal littermates.   
  In summary, the significant negative correlation seen in this study between diastolic/ 
mean BP and iNOS mRNA in conjunction with IH, but not CH, exposure at the end of the day 3 
IH session implies that IH may elicit a compensatory biologic response. The results of this study 
support the thinking that IH is a more potent stressor than CH in regard to influencing iNOS 
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 expression and its subsequent mediation of BP, but variability in the response may be 
attributable to variability in iNOS induction. The lack of consensus among studies, however, 
suggests that e.g., the frequency, duration and intensity of hypoxic stress is influential in 
regulating hypoxia inducible genes in ways that have yet to be fully elucidated. Nonetheless, 
ongoing efforts to identify and understand the relationship between molecular and cardiovascular 
response to hypoxia may help to provide improved comprehension of the inter-individual 
differences in the physiologic response of humans to different patterns of hypoxic stimulus. 
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